Found: 10
Select item for more details and to access through your institution.
The lysophospholipase D enzyme Gdpd3 is required to maintain chronic myelogenous leukaemia stem cells.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. N.PAG, doi. 10.1038/s41467-020-18491-9
- By:
- Publication type:
- Article
Need for Flexible Adjustment of the Treatment Schedule for Aprepitant Administration against Erlotinib-Induced Refractory Pruritus and Skin Rush.
- Published in:
- Case Reports in Oncology, 2019, v. 12, n. 1, p. 84, doi. 10.1159/000493256
- By:
- Publication type:
- Article
Promising Combination Therapy with Bevacizumab and Erlotinib in an EGFR-Mutated NSCLC Patient with MET Amplification Who Showed Intrinsic Resistance to Initial EGFR-TKI Therapy.
- Published in:
- Case Reports in Oncology, 2019, v. 12, n. 1, p. 91, doi. 10.1159/000493088
- By:
- Publication type:
- Article
Significance of Earlier Initiation of Chemotherapy for Lung Cancer Complicated with Primary or Secondary Nephrotic Syndrome following Its Appropriate Differential Diagnosis.
- Published in:
- Case Reports in Oncology, 2019, v. 12, n. 1, p. 53, doi. 10.1159/000493851
- By:
- Publication type:
- Article
Successful Treatment with Taxane-Based Chemotherapy in Advanced Sebaceous Carcinoma: A Case Report and Literature Review.
- Published in:
- Case Reports in Oncology, 2019, v. 12, n. 1, p. 47, doi. 10.1159/000493850
- By:
- Publication type:
- Article
Prospective analysis of factors precluding the initiation of durvalumab from an interim analysis of a phase II trial of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small cell lung cancer in Japan (SAMURAI study)
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221116603
- By:
- Publication type:
- Article
Plasma exosomal DOK3 reflects immunological states in lung tumor and predicts prognosis of gefitinib treatment.
- Published in:
- Cancer Science, 2022, v. 113, n. 11, p. 3960, doi. 10.1111/cas.15512
- By:
- Publication type:
- Article
Detailed profiling of polysorbate 80 oxidative degradation products and hydrolysates using liquid chromatography– tandem mass spectrometry analysis.
- Published in:
- Rapid Communications in Mass Spectrometry: RCM, 2024, v. 38, n. 7, p. 1, doi. 10.1002/rcm.9715
- By:
- Publication type:
- Article
Profiling polysorbate 80 components using comprehensive liquid chromatography–tandem mass spectrometry analysis.
- Published in:
- Rapid Communications in Mass Spectrometry: RCM, 2023, v. 37, n. 6, p. 1, doi. 10.1002/rcm.9438
- By:
- Publication type:
- Article
A single arm Phase I/II trial on the combination of carboplatin, nab-paclitaxel and avastin as first-line treatment for advanced non-squamous non-small cell lung cancer (TORG1424/OLCSG1402: CARNAVAL).
- Published in:
- Japanese Journal of Clinical Oncology, 2024, v. 54, n. 7, p. 805, doi. 10.1093/jjco/hyae044
- By:
- Publication type:
- Article